ArticleSignal transduction and targeted therapy2025

High mtDNA content identifies oxidative phosphorylation-driven acute myeloid leukemias and represents a therapeutic vulnerability.

Diego A Pereira-Martins et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.